ASCRS Glaucoma Day | ASCRS
thumbprint
Apr 10, 2026
Washington, D.C.

ASCRS Glaucoma Day

From AI-driven diagnostics to advanced surgical techniques, Glaucoma Day 2026 delivers a full day of forward-thinking education. Join the field’s leading minds for a dynamic program that blends innovation, clinical insight, and real-world strategies to elevate your glaucoma care.


Glaucoma Day 2026: Precision, Progress, and Purpose

Led by Program Co-Chairs Nathan Radcliffe, MD, and Manjool Shah, MD, Glaucoma Day 2026 delivers a high-impact agenda spanning the latest in surgical innovation, diagnostics, interventional therapies, and patient-centered care.

From AI and robotics to advanced MIGS techniques and lifestyle-focused strategies, this full-day program offers practical insights, expert-led discussions, and real-world case reviews. Whether you're managing complex cases or exploring the future of glaucoma care, this is your opportunity to learn, connect, and lead.


Program Chairs

Nate Radcliffe, MD

Chair

Manjool Shah, MD

Co-chair

CME Mission Statement

ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought.

Accreditation Statement

The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Society of Cataract and Refractive Surgery designates this Other (blended live and enduring material), for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit.

Physicians can claim CME credit up to the maximum listed above for attending the Physicians Program (ASCRS), including scientific films and posters on-demand, scientific papers, courses, symposia and general sessions). Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits. Note: All attendees must have their badges to be eligible to claim credits and evaluate the program.

Target Audience

Practicing ophthalmologists who care for patients with glaucomarelated conditions.

Educational Objectives

  • Effectively evaluate current and new diagnostic testing modalities to assist in the early diagnosis of the glaucoma patient and glaucoma suspect as well as disease progression
  • Make treatment decisions using evidence-based recommendations regarding the use of pharmacologic and laser therapies for the treatment of glaucoma
  • Evaluate best phacoemulsification treatment options and considerations for patients with complex, pre-existing, and advanced glaucoma
  • Discuss recent and emerging microinvasive glaucoma surgical (MIGS) options
  • Integrate pearls to improve glaucoma surgical outcomes
  • Implement strategies to manage glaucoma surgical outcomes
  • Give examples of how to include AI and/or Virtual Reality in glaucoma treatments